Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support...
Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support...
IRVINE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on...
NEW YORK, Dec. 30, 2021 /PRNewswire/ -- Jscreen.org, a national nonprofit that provides accessible and affordable genetic testing, education, and...
- Ray Huggenberger Retires from Board - GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory...
Independent Certification Enables the Company to Produce for Major Retailers WorldwideHICKSVILLE, NY / ACCESSWIRE / December 30, 2021 / Can...
Ad hoc announcement pursuant to Art. 53 LRALLSCHWIL, SWITZERLAND / ACCESSWIRE / December 30, 2021 / Polyphor AG (SIX:POLN) and...
GENEVA, SWITZERLAND / ACCESSWIRE / December 30, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...
SHANGHAI, Dec. 29, 2021 /PRNewswire/ -- Kimberly-Clark (China) Co., Ltd., the global leader in the personal care and hygiene industry, and...